Quality key factors
Factor
Value
Sales Growth (5y)
14.30%
EBIT Growth (5y)
-101.18%
EBIT to Interest (avg)
2.41
Debt to EBITDA (avg)
4.31
Net Debt to Equity (avg)
0.42
Sales to Capital Employed (avg)
1.24
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
13.36%
ROCE (avg)
-0.10%
ROE (avg)
11.75%
Valuation Key Factors 
Factor
Value
P/E Ratio
308
Industry P/E
33
Price to Book Value
2.39
EV to EBIT
-2443.42
EV to EBITDA
52.85
EV to Capital Employed
2.53
EV to Sales
1.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.10%
ROE (Latest)
0.78%
Loading Valuation Snapshot...
9What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 23.66 times
PBT LESS OI(Q)
At Rs 71.71 cr has Grown at 77.7% (vs previous 4Q average
PAT(9M)
Higher at Rs 184.39 Cr
-3What is not working for the Company
PAT(Latest six months)
At Rs 124.22 cr has Grown at -47.11%
Loading Valuation Snapshot...
Here's what is working for Akums Drugs
Operating Profit to Interest - Quarterly
Highest at 23.66 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 71.71 cr has Grown at 77.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 40.36 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Here's what is not working for Akums Drugs
Profit After Tax (PAT) - Latest six months
At Rs 124.22 cr has Grown at -47.11%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Non Operating Income - Quarterly
Highest at Rs 14.56 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income